TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Pharmapress Oy
Closing information (x1000 SEK)
Closing information | 2017/12 | 2016/12 | 2015/12 |
Turnover | 10,835 | 11,700 | 12,597 |
Financial expenses | 0 | ||
Earnings before taxes | 670 | 497 | 630 |
Total assets | 6,412 | 6,094 | 5,856 |
Current assets | 3,635 | 4,927 | 4,531 |
Current liabilities | 1,212 | 1,081 | 977 |
Equity capital | 5,191 | 5,013 | 4,869 |
- share capital | 295 | 287 | 274 |
Financial ratios
Fiscal year | 2017/12 | 2016/12 | 2015/12 |
Solvency | 81.0% | 82.3% | 83.1% |
Turnover per employee | |||
Profit as a percentage of turnover | 6.2% | 4.2% | 5.0% |
Return on assets (ROA) | 10.8% | ||
Current ratio | 299.9% | 455.8% | 463.8% |
Return on equity (ROE) | 12.9% | 9.9% | 12.9% |
Change turnover | -1,212 | -1,492 | -977 |
Change turnover % | -10% | -11% | -7% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2017/12 | 2016/12 | 2015/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.